Robert Gene Rand

US Patent:

20160331759, Nov 17, 2016

Filed:

Jul 29, 2016

Appl. No.:

15/223604

Inventors:

Robert Rand - New York NY, US

International Classification:

A61K 31/55
A61K 47/12
A61K 31/51
A61K 31/525
A61K 31/375
A61K 31/197
A61K 31/4415
A61K 31/4188
A61K 31/519
A61K 31/714
A61K 47/38
A61K 31/455

Abstract:

A medicinal composition is administered orally twice a day to a patient to ameliorate the symptoms related to Parkinson's disease. The medicinal composition includes mixing a quantity of ibogaine, a quantity of vitamin supplements and a quantity of manufacturing additives into a heterogeneous medicinal mixture. The quantity of ibogaine, formulated as ibogaine HCl, other non-toxic salts of ibogaine (an alkaloid of the family apocynaceae), or noribogaine, its active metabolite, is an active ingredient to regulate endogenous glial cell line-derived neurotrophic factor (GDNF). The quantity of vitamin supplements promotes the general health and neurological functions. The quantity of manufacturing additives bonds the quantity of ibogaine and the quantity of vitamin supplements together, as well as, provides anti-adherent properties to prevent the medicinal mixture from adhering to manufacturing equipment.